Expanded specific T cells to hypomutated regions of the SARS-CoV-2 using mRNA electroporated antigen-presenting cells.

Autor: Ogando-Rivas E; UF Brain Tumor Immunotherapy Program, Preston A. Wells Center for Brain Tumor Therapy, Lillian S. Wells Department of Neurosurgery, University of Florida, Gainesville, FL, USA., Castillo P; UF Division of Pediatric Hematology Oncology, Department of Pediatrics, University of Florida, Gainesville, FL, USA., Yang C; UF Brain Tumor Immunotherapy Program, Preston A. Wells Center for Brain Tumor Therapy, Lillian S. Wells Department of Neurosurgery, University of Florida, Gainesville, FL, USA., Trivedi V; UF Brain Tumor Immunotherapy Program, Preston A. Wells Center for Brain Tumor Therapy, Lillian S. Wells Department of Neurosurgery, University of Florida, Gainesville, FL, USA., Zhang D; UF Brain Tumor Immunotherapy Program, Preston A. Wells Center for Brain Tumor Therapy, Lillian S. Wells Department of Neurosurgery, University of Florida, Gainesville, FL, USA., Pohl-Guimarães F; UF Brain Tumor Immunotherapy Program, Preston A. Wells Center for Brain Tumor Therapy, Lillian S. Wells Department of Neurosurgery, University of Florida, Gainesville, FL, USA., Liu R; UF Brain Tumor Immunotherapy Program, Preston A. Wells Center for Brain Tumor Therapy, Lillian S. Wells Department of Neurosurgery, University of Florida, Gainesville, FL, USA., Barpujari A; UF Division of Pediatric Hematology Oncology, Department of Pediatrics, University of Florida, Gainesville, FL, USA., Candelario KM; UF Brain Tumor Immunotherapy Program, Preston A. Wells Center for Brain Tumor Therapy, Lillian S. Wells Department of Neurosurgery, University of Florida, Gainesville, FL, USA., Mendez-Gomez H; UF Brain Tumor Immunotherapy Program, Preston A. Wells Center for Brain Tumor Therapy, Lillian S. Wells Department of Neurosurgery, University of Florida, Gainesville, FL, USA., Sayour EJ; UF Brain Tumor Immunotherapy Program, Preston A. Wells Center for Brain Tumor Therapy, Lillian S. Wells Department of Neurosurgery, University of Florida, Gainesville, FL, USA.; UF Division of Pediatric Hematology Oncology, Department of Pediatrics, University of Florida, Gainesville, FL, USA., Mitchell DA; UF Brain Tumor Immunotherapy Program, Preston A. Wells Center for Brain Tumor Therapy, Lillian S. Wells Department of Neurosurgery, University of Florida, Gainesville, FL, USA.

Publikováno v: Molecular therapy. Methods & clinical development [Mol Ther Methods Clin Dev] 2024 Jan 22; Vol. 32 (1), pp. 101192. Date of Electronic Publication: 2024 Jan 22 (Print Publication: 2024).

The current landscape of immunotherapy for pediatric brain tumors.

Autor: Hwang EI; Division of Oncology, Brain Tumor Institute, Children's National Hospital, Washington, DC, USA. ehwang@childrensnational.org., Sayour EJ; Department of Neurosurgery, Preston A. Wells, Jr. Center for Brain Tumor Therapy, University of Florida, Gainesville, FL, USA., Flores CT; Department of Neurosurgery, Preston A. Wells, Jr. Center for Brain Tumor Therapy, University of Florida, Gainesville, FL, USA., Grant G; Division of Pediatric Neurosurgery, Lucile Packard Children's Hospital, Stanford University, Palo Alto, CA, USA., Wechsler-Reya R; Tumor Initiation & Maintenance Program, NCI-Designated Cancer Center, Sanford Burnham Prebys Medical Discovery Institute, La Jolla, CA, USA., Hoang-Minh LB; Department of Neurosurgery, Preston A. Wells, Jr. Center for Brain Tumor Therapy, University of Florida, Gainesville, FL, USA., Kieran MW; Day One Biopharmaceuticals, San Francisco, CA, USA., Salcido J; Brain Tumor Foundation, Ashville, NC, USA., Prins RM; Departments of Neurosurgery and Molecular and Medical Pharmacology, David Geffen School of Medicine at UCLA, Los Angeles, CA, USA., Figg JW; Department of Neurosurgery, Preston A. Wells, Jr. Center for Brain Tumor Therapy, University of Florida, Gainesville, FL, USA., Platten M; Department of Neurology, Medical Faculty Mannheim, MCTN, Heidelberg University and CCU Brain Tumor Immunology, DKFZ, Heidelberg, Germany., Candelario KM; Department of Neurosurgery, Preston A. Wells, Jr. Center for Brain Tumor Therapy, University of Florida, Gainesville, FL, USA., Hale PG; Children's Brain Trust, Coral Springs, FL, USA., Blatt JE; Department of Neurosurgery, Preston A. Wells, Jr. Center for Brain Tumor Therapy, University of Florida, Gainesville, FL, USA., Governale LS; Department of Neurosurgery, Preston A. Wells, Jr. Center for Brain Tumor Therapy, University of Florida, Gainesville, FL, USA., Okada H; Department of Neurosurgery, University of California, San Francisco, CA, USA., Mitchell DA; Department of Neurosurgery, Preston A. Wells, Jr. Center for Brain Tumor Therapy, University of Florida, Gainesville, FL, USA., Pollack IF; Department of Neurological Surgery, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA.

Publikováno v: Nature cancer [Nat Cancer] 2022 Jan; Vol. 3 (1), pp. 11-24. Date of Electronic Publication: 2022 Jan 20.

Hypoxia inducible factor-1α (HIF-1α) is required for neural stem cell maintenance and vascular stability in the adult mouse SVZ.

Autor: Li L; Department of Neurosciences, University of New Mexico Health Sciences Center, School of Medicine, Albuquerque, New Mexico 87131., Candelario KM; Department of Neurosciences, University of New Mexico Health Sciences Center, School of Medicine, Albuquerque, New Mexico 87131., Thomas K; Department of Neurosciences, University of New Mexico Health Sciences Center, School of Medicine, Albuquerque, New Mexico 87131., Wang R; Department of Neurosciences, University of New Mexico Health Sciences Center, School of Medicine, Albuquerque, New Mexico 87131., Wright K; Department of Neurosciences, University of New Mexico Health Sciences Center, School of Medicine, Albuquerque, New Mexico 87131., Messier A; Department of Neurosciences, University of New Mexico Health Sciences Center, School of Medicine, Albuquerque, New Mexico 87131., Cunningham LA; Department of Neurosciences, University of New Mexico Health Sciences Center, School of Medicine, Albuquerque, New Mexico 87131 leeanna@salud.unm.edu.

Publikováno v: The Journal of neuroscience : the official journal of the Society for Neuroscience [J Neurosci] 2014 Dec 10; Vol. 34 (50), pp. 16713-9.

Regenerative medicine in Alzheimer's disease.

Autor: Felsenstein KM; Department of Neuroscience, University of Florida, Gainesville, Fla; McKnight Brain Institute, University of Florida, Gainesville, Fla; Center for Translational Research in Neurodegenerative Disease, University of Florida, Gainesville, Fla., Candelario KM; Department of Neurosurgery, University of Florida, Gainesville, Fla; McKnight Brain Institute, University of Florida, Gainesville, Fla., Steindler DA; Department of Neurosurgery, University of Florida, Gainesville, Fla; McKnight Brain Institute, University of Florida, Gainesville, Fla., Borchelt DR; Department of Neuroscience, University of Florida, Gainesville, Fla; McKnight Brain Institute, University of Florida, Gainesville, Fla; Center for Translational Research in Neurodegenerative Disease, University of Florida, Gainesville, Fla; SantaFe HealthCare Alzheimer's Disease Research Center, University of Florida, Gainesville, Fla. Electronic address: drb1@ufl.edu.

Publikováno v: Translational research : the journal of laboratory and clinical medicine [Transl Res] 2014 Apr; Vol. 163 (4), pp. 432-8. Date of Electronic Publication: 2013 Nov 08.